Geron Corporation (GERN)
Healthcare
Biotechnology
1.30 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -111 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.4 | -24 | -18 | -21 | -21 | -44 | -67 | -96 | -127 | -168 | -219 | -111 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.8 | 0.9 | 0.8 | 0.9 | 1.0 | 1.2 | 1.2 | |
| 7.7 | 8.4 | 8.2 | 8.1 | 6.4 | 6.1 | 6.9 | 8.1 | 8.0 | 19 | 31 | 0.1 | |
| 7.6 | 8.7 | 9.0 | 8.7 | 7.2 | 6.4 | 6.7 | 6.9 | 8.3 | – | – | – | |
| 34 | -35 | 2.1 | -1.4 | -0.2 | 19 | 0.4 | 11 | 5.0 | 6.1 | -68 | -69 | |
| 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.4 | 0.4 | 0.2 | 0.4 | 0.8 | 0.7 | 0.0 | |
| -78 | 0.1 | 8.8 | 23 | -78 | 27 | -105 | 72 | 62 | -180 | -106 | 107 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 98 | 2.6 | 1.2 | 1.1 | 93 | 19 | 4.3 | 24 | 17 | – | – | – | |
| – | – | – | 24 | 24 | 24 | 24 | 25 | 0.0 | 30 | 35 | 0.0 | |
| 98 | 2.6 | 1.2 | 1.1 | 93 | 19 | 168 | 49 | 87 | 362 | 334 | 2.3 | |
| 30 | -22 | -8.4 | 3.5 | -5.8 | 3.1 | -3.6 | 25 | 22 | 14 | 9.7 | -1.4 | |
| 9.2 | -24 | -18 | -21 | -21 | -44 | -67 | -96 | -128 | -169 | -219 | -111 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.